<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gamble, John-Michael</style></author><author><style face="normal" font="default" size="100%">Alkabbani, Wajd</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Authors' Reply to Noguchi's comment on: ``Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data''</style></title><secondary-title><style face="normal" font="default" size="100%">DRUG SAFETY</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">JUL</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">7</style></number><volume><style face="normal" font="default" size="100%">45</style></volume><pages><style face="normal" font="default" size="100%">813-814</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>